Litigation
Jun. 13, 2014
Patent office gains traction for drug disputes
The battles between brand-name drug companies and their generic drug counterparts have typically played out in the marketplace and district courts, but a new venue has emerged that could change the competitive landscape.
Daily Journal Staff Writer
The multi-million dollar battles between brand-name drug companies and their generic drug counterparts have typically played out in the marketplace and district courts, but a new venue has emerged that could change the competitive landscape.
Generic drug producers are now challenging the pharmaceutical patents held by brand name companies in the U.S. Patent and Trademark Office. These generic companies a...
For only $95 a month (the price of 2 article purchases)
Receive unlimited article access and full access to our archives,
Daily Appellate Report, award winning columns, and our
Verdicts and Settlements.
Or
$795 for an entire year!
Or access this article for $45
(Purchase provides 7-day access to this article. Printing, posting or downloading is not allowed.)
Already a subscriber?
Sign In